Analyst Consensus ?
ConsensusHold45 ratings
Bullish1840.0%
Neutral2453.3%
Bearish36.7%
FN2 Earnings Intelligence
The Allstate Corporation analyst ratings
The Allstate Corporation (ALL) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$251.71Current
$119Low
$238.16Average
$319High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 27, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Wells Fargo | Equal Weight | Underweight | Upgrade | Oct 12, 2026 |
| Keefe, Bruyette & Woods | Underperform | Underperform | Maintain | Oct 12, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Oct 7, 2026 |
| Barclays | Underweight | Underweight | Maintain | Oct 7, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Oct 6, 2026 |
| Citigroup | Sell | Sell | Maintain | Oct 2, 2026 |
| Goldman Sachs | Neutral | Neutral | Maintain | Oct 1, 2026 |
| Argus Research | Hold | Buy | Downgrade | Aug 28, 2026 |
| BMO Capital | Buy | Buy | Maintain | Aug 13, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Aug 11, 2026 |
| UBS | Neutral | Neutral | Maintain | Aug 10, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Aug 10, 2026 |
| Freedom Broker | Buy | Hold | Upgrade | Aug 7, 2026 |
| Roth MKM | Buy | Buy | Maintain | Aug 6, 2026 |
| Evercore ISI Group | In Line | In Line | Maintain | Aug 6, 2026 |
| Cantor Fitzgerald | Neutral | Neutral | Maintain | Jul 9, 2026 |
| Raymond James | Strong Buy | Strong Buy | Maintain | Jul 6, 2026 |
| HSBC | Hold | Buy | Downgrade | Jul 6, 2026 |
| TD Cowen | Hold | Buy | Downgrade | Jan 12, 2026 |
| William Blair | Market Perform | Outperform | Downgrade | Dec 18, 2025 |
| Roth Capital | Buy | Buy | Maintain | Nov 26, 2025 |
| Jefferies | Buy | Buy | Maintain | Aug 11, 2025 |
| B of A Securities | Buy | Buy | Maintain | Oct 18, 2024 |
| CFRA | Hold | Buy | Downgrade | Oct 21, 2022 |
| MKM Partners | Buy | Buy | Maintain | Oct 20, 2022 |
| Credit Suisse | Outperform | Outperform | Maintain | Apr 28, 2022 |
| Wolfe Research | Perform | Peer Perform | Maintain | Aug 17, 2021 |
| Deutsche Bank | Hold | Hold | Maintain | May 13, 2021 |
| Buckingham Research | Neutral | Neutral | Maintain | Sep 12, 2019 |
| Buckingham | Neutral | Neutral | Maintain | Sep 12, 2019 |
| Compass Point | Buy | Buy | Maintain | Jan 15, 2019 |
| B. Riley Securities | Neutral | Neutral | Maintain | Aug 7, 2018 |
| B. Riley FBR | Neutral | Neutral | Maintain | Aug 7, 2018 |
| Argus | Buy | Buy | Maintain | May 9, 2018 |
| Keefe Bruyette & Woods | Market Perform | Underperform | Upgrade | Apr 2, 2018 |
| Bank of America | Buy | Buy | Maintain | Feb 8, 2018 |
| Macquarie | Neutral | Outperform | Downgrade | Apr 19, 2017 |
| Nomura | Neutral | Neutral | Maintain | Feb 4, 2016 |
| PiperJaffray | Overweight | Overweight | Maintain | Oct 15, 2015 |
| Sandler O'Neill | Buy | Hold | Upgrade | Sep 21, 2015 |
| RBC Capital | Sector Perform | Outperform | Downgrade | Aug 4, 2015 |
| FBR Capital | Market Perform | Market Perform | Maintain | Oct 1, 2014 |
| Guggenheim | Buy | Buy | Maintain | Sep 18, 2013 |
| SunTrust Robinson Humphrey | Neutral | Neutral | Maintain | Sep 27, 2012 |
| Drexel Hamilton | Hold | Hold | Maintain | Aug 1, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $251.71. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Wells Fargo | Elyse Greenspan | $236 | $229.43 | -6.2% | Oct 12, 2026 |
| Mizuho Securities | Analyst unavailable | $295 | $224.27 | +17.2% | Oct 7, 2026 |
| Barclays | Alex Scott | $221 | $224.27 | -12.2% | Oct 7, 2026 |
| HSBC | Analyst unavailable | $266 | $224.27 | +5.7% | Oct 7, 2026 |
| Goldman Sachs | Analyst unavailable | $250 | $221.86 | -0.7% | Oct 1, 2026 |
| Mizuho Securities | Analyst unavailable | $300 | $252.21 | +19.2% | Sep 18, 2026 |
| Mizuho Securities | Analyst unavailable | $297 | $257.21 | +18.0% | Sep 16, 2026 |
| Argus Research | Kevin Heal | $238 | $257.62 | -5.4% | Aug 28, 2026 |
| Morgan Stanley | Analyst unavailable | $265 | $267.77 | +5.3% | Aug 11, 2026 |
| Raymond James | Analyst unavailable | $315 | $266.31 | +25.1% | Aug 11, 2026 |
| UBS | Analyst unavailable | $275 | $271.07 | +9.3% | Aug 10, 2026 |
| Goldman Sachs | Robert Cox | $280 | $275.11 | +11.2% | Aug 7, 2026 |
| Wells Fargo | Analyst unavailable | $250 | $275.11 | -0.7% | Aug 7, 2026 |
| Roth Capital | Analyst unavailable | $300 | $264.59 | +19.2% | Aug 6, 2026 |
| Barclays | Alex Scott | $226 | $264.59 | -10.2% | Aug 6, 2026 |
| Roth Capital | Analyst unavailable | $275 | $248.55 | +9.3% | Jul 17, 2026 |
| Atlantic Equities | Analyst unavailable | $319 | $240.55 | +26.7% | Jul 15, 2026 |
| UBS | Analyst unavailable | $261 | $250.35 | +3.7% | Jul 15, 2026 |
| Evercore ISI | David Motemaden | $240 | $250.59 | -4.7% | Jul 10, 2026 |
| Cantor Fitzgerald | Ryan Tunis | $242 | $249.27 | -3.9% | Jul 9, 2026 |
| Mizuho Securities | Analyst unavailable | $272 | $251.17 | +8.1% | Jul 9, 2026 |
| Barclays | Alex Scott | $213 | $248.37 | -15.4% | Jul 7, 2026 |
| Raymond James | Analyst unavailable | $300 | $248.04 | +19.2% | Jul 6, 2026 |
| Morgan Stanley | Bob Huang | $240 | $250.33 | -4.7% | Jul 6, 2026 |
| HSBC | Vikram Gandhi | $264 | $250.33 | +4.9% | Jul 6, 2026 |
| Piper Sandler | Analyst unavailable | $268 | $217.26 | +6.5% | May 1, 2026 |
| Raymond James | Gregory Peters | $260 | $213.61 | +3.3% | Mar 3, 2026 |
| Mizuho Securities | Analyst unavailable | $281 | $207.55 | +11.6% | Feb 9, 2026 |
| Goldman Sachs | Analyst unavailable | $238 | $207.55 | -5.4% | Feb 7, 2026 |
| Wells Fargo | Elyse Greenspan | $228 | $212.13 | -9.4% | Feb 6, 2026 |
| Mizuho Securities | Analyst unavailable | $255 | $197.65 | +1.3% | Jan 14, 2026 |
| Wells Fargo | Analyst unavailable | $223 | $208.66 | -11.4% | Jan 13, 2026 |
| Goldman Sachs | Analyst unavailable | $227 | $207.27 | -9.8% | Jan 7, 2026 |
| Evercore ISI | Analyst unavailable | $225 | $208.97 | -10.6% | Jan 7, 2026 |
| Morgan Stanley | Bob Huang | $215 | $211.69 | -14.6% | Dec 16, 2025 |
| Mizuho Securities | Yaron Kinar | $254 | $211.69 | +0.9% | Dec 15, 2025 |
| Roth Capital | Harry Fong | $240 | $212.65 | -4.7% | Nov 26, 2025 |
| UBS | Analyst unavailable | $250 | $213.06 | -0.7% | Oct 8, 2025 |
| Evercore ISI | David Motemaden | $233 | $214.65 | -7.4% | Oct 1, 2025 |
| Roth Capital | Analyst unavailable | $230 | $209.82 | -8.6% | Sep 26, 2025 |
| Wells Fargo | Analyst unavailable | $202 | $205.55 | -19.7% | Aug 5, 2025 |
| Barclays | Alex Scott | $198 | $192.28 | -21.3% | Jul 31, 2025 |
| Wells Fargo | Elyse Greenspan | $197 | $200.17 | -21.7% | May 6, 2025 |
| Raymond James | Gregory Peters | $250 | $200.25 | -0.7% | May 5, 2025 |
| Wells Fargo | Elyse Greenspan | $187 | $186.04 | -25.7% | Jan 14, 2025 |
| BMO Capital | Michael Zaremski | $214 | $195.51 | -15.0% | Oct 18, 2024 |
| Bank of America Securities | Joshua Shanker | $233 | $195.51 | -7.4% | Oct 18, 2024 |
| Bank of America Securities | Joshua Shanker | $216 | $184.91 | -14.2% | Oct 10, 2024 |
| Raymond James | Gregory Peters | $220 | $187.84 | -12.6% | Oct 4, 2024 |
| Wells Fargo | Elyse Greenspan | $175 | $178.11 | -30.5% | Aug 16, 2024 |
| Piper Sandler | Paul Newsome | $196 | $178.11 | -22.1% | Aug 16, 2024 |
| CFRA | Catherine Seifert | $200 | $180.95 | -20.5% | Aug 14, 2024 |
| Wells Fargo | Elyse Greenspan | $177 | $171.03 | -29.7% | Aug 12, 2024 |
| Jefferies | Yaron Kinar | $217 | $169.02 | -13.8% | Aug 5, 2024 |
| BMO Capital | Michael Zaremski | $205 | $176.82 | -18.6% | Aug 5, 2024 |
| BMO Capital | Michael Zaremski | $191 | $176.69 | -24.1% | Jul 18, 2024 |
| Piper Sandler | Paul Newsome | $188 | $173.01 | -25.3% | Apr 1, 2024 |
| HSBC | Vikram Gandhi | $190 | $169.84 | -24.5% | Mar 28, 2024 |
| Wells Fargo | Analyst unavailable | $104 | $131.68 | -58.7% | Feb 3, 2023 |
| Evercore ISI | Analyst unavailable | $138 | $131.53 | -45.2% | Feb 2, 2023 |
| Piper Sandler | Analyst unavailable | $153 | $140.01 | -39.2% | Jan 10, 2023 |
| Goldman Sachs | Analyst unavailable | $166 | $140.36 | -34.1% | Jan 9, 2023 |
| Morgan Stanley | Analyst unavailable | $137 | $134.26 | -45.6% | Nov 22, 2022 |
| Credit Suisse | Andrew Kligerman | $188 | $121.39 | -25.3% | Sep 2, 2022 |
| Morgan Stanley | Analyst unavailable | $140 | $131.18 | -44.4% | Aug 19, 2022 |
| Piper Sandler | Analyst unavailable | $147 | $141.13 | -41.6% | Apr 22, 2022 |
| Raymond James | Gregory Peters | $165 | $141.8 | -34.4% | Mar 27, 2022 |
| Raymond James | Gregory Peters | $145 | $125.88 | -42.4% | Mar 14, 2022 |
| Goldman Sachs | Alex Scott | $142 | $125.68 | -43.6% | Mar 3, 2022 |
| Jefferies | Yaron Kinar | $122 | $121.54 | -51.5% | Jan 6, 2022 |
| Barclays | Tracy Benguigui | $119 | $121.54 | -52.7% | Jan 6, 2022 |
| Deutsche Bank | Phil Stefano | $131 | $134 | -48.0% | May 13, 2021 |
| Argus Research | Kevin Heal | $155 | $131.05 | -38.4% | May 10, 2021 |
Track every rating change on ALL the moment it posts. Free to start.
Start freeGet the ALL recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.